Avita Medical, Inc. Common Stock (RCEL) Stock Price
RCELStock
$10.50+103.07%52W
Market Cap$324.73M
P/E—
PEG Ratio—
Div yield—
Beta1.96
RCEL Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)118.68%
Price vs S&P 500 (4W)111.92%
VGM Score54.63
RCEL Earnings Surprise History
Q2 25-0.58est. -0.36
Q3 25-0.71est. -0.45
Q4 25-0.54est. -0.55
Q1 26-0.48est. -0.38
Q2 26-0.36est. -0.39
RCEL Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.00
4.09
4.10
3.90
Industry Peers — Surgical & Medical Instruments(140)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RCELAvita Medical, Inc. Common Stock | D | C | A | $10.50 |
| SYKStryker Corporation | C | B | C | $330.59 |
| MMM3M Company | C | D | B | $179.37 |
| BSXBoston Scientific Corp. | C | B | D | $49.86 |
| BDXBecton, Dickinson and Co. | B | D | B | $189.78 |
| MDLNMedline Inc. Class A common stock | C | D | C | $35.64 |
| RMDResMed Inc. | C | B | C | $236.59 |
| DXCMDexCom, Inc. | D | B | B | $89.16 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $348.48 |
| SOLVSolventum Corporation | C | C | B | $91.61 |
| BAXBaxter International Inc. | B | D | B | $26.29 |
About Avita Medical, Inc. Common Stock
Avita is a medical device company focused on the RECELL system, a proprietary burn treatment technology that creates Spray-on Skin from small patient samples in approximately 30 minutes, reducing the need for traditional skin grafts. The FDA-approved system is used across most of the nation's 140 burn centers and has expanded indications for soft-tissue reconstruction. While holding approvals in multiple countries, Avita focuses primarily on the US market, though international sales—particularly in Japan—are growing.